Mechanisms for negative regulation ofTAK1/MAPKKK in innate immune responses
先天免疫反应中 TAK1/MAPKKK 负调控机制
基本信息
- 批准号:18570180
- 负责人:
- 金额:$ 2.57万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
TAK1, a member of the MAPKKK family protein kinases, plays a pivotal role in interleukin-1 signaling pathway as well as Toll-like receptor signaling pathway. Upon ligand binding, TAK1 is rapidly and transiently activated. Although there have been extensive studies on the activation mechanism of TAK1, it is still unclear how TAK1 activation is terminated. To identify negative regulator(s) for TAK1, we searched protein(s) that form a complex with activated TAK1. To this end,we first established HeLa cells stably expressing Tandem affinity purification (TAP)-tagged TAK1 at the level close to the endogenous one. Then, TAP-TAK1 was purified from the cells stimulated with IL-1beta, and co-purifiying proteins were identified by mass spectrometry. We identified an E3 ubiquitinligase X as a novel TAK1-binding protein. Biochemical analysis revealed that X can strongly inhibit TAK1-induced activation of NF-κB and coexpression of X significantly reduces the amount of TAK1-activator, TAB1. These results suggest that X is a good candidate for yet-to-be-identified negative regulator of TAK1. This study will contribute to our full understanding of how TAK1 is regulated in cytokine signaling as well as innate immune responses.We have also studied a mechanism of TAK1 activation by HTLV-1 Tax protein. We found that Tax interacts with an adapter protein TAB2 and activates TAK1. Ubiquitination of Tax is likely to be essential for its ability to activate TAK1. Importantly,we demonstrated that TRAF2, 5, and 6 ofTRAF family proteins can induce polyubiquitination of Tax. To our knowledge, this is the first report on the cellular E3 ubiquitinligases towards Tax. This study should shed light on the molecular mechanisms for the oncogenic action of Tax.
TAK1是MAPKKK家族蛋白激酶的成员之一,在白细胞介素1信号通路和Toll样受体信号通路中起着关键作用。在配体结合后,TAK1被快速且瞬时地激活。尽管对TAK1的激活机制已有广泛的研究,但TAK1的激活是如何终止的仍不清楚。为了鉴定TAK1的负调节因子,我们搜索了与活化的TAK1形成复合物的蛋白质。为此,我们首先建立了HeLa细胞稳定表达串联亲和纯化(TAP)标记的TAK1在接近内源性的水平。然后,从IL-1 β刺激的细胞中纯化TAP-TAK1,并通过质谱鉴定共纯化蛋白。我们鉴定了一种E3泛素连接酶X作为一种新的TAK1结合蛋白。生化分析表明,X可以强烈抑制TAK1诱导的NF-κ B活化,X的共表达显著降低TAK1活化剂TAB1的量。这些结果表明,X是一个很好的候选人尚未被确定的TAK1的负调节。本研究将有助于我们全面了解TAK1在细胞因子信号传导和先天免疫应答中的调节作用,并研究了HTLV-1 Tax蛋白激活TAK1的机制。我们发现Tax与衔接蛋白TAB2相互作用并激活TAK1。税收的普遍化可能是其激活TAK1能力的关键。重要的是,我们证明TRAF家族蛋白中的TRAF 2、5和6可以诱导Tax的多聚泛素化。据我们所知,这是第一个关于细胞E3泛素连接酶对Tax的报道。这项研究将有助于阐明Tax致癌作用的分子机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Peptidoglycan and lipopolysaccharide activate PLCγ2, leading to enhanced cytokine production in macrophages and dendritic cells
- DOI:10.1111/j.1365-2443.2007.01159.x
- 发表时间:2008-02-01
- 期刊:
- 影响因子:2.1
- 作者:Aki, Daisuke;Minoda, Yasumasa;Yoshimura, Akihiko
- 通讯作者:Yoshimura, Akihiko
A novel Zinc finger protein, ZCCHCll, interacts with TIFA and modulates TLR signaling
一种新型锌指蛋白 ZCCHCll 与 TIFA 相互作用并调节 TLR 信号传导
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Minoda;Yasumasa;et. al.
- 通讯作者:et. al.
Peptidoglycan and lipopolysaccharide activate PLCgamma2, leading to enhanced cytokine production in macrophages and dendritic cells
肽聚糖和脂多糖激活 PLCgamma2,导致巨噬细胞和树突细胞中细胞因子的产生增强
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Aki D;Minoda Y;Yoshida R;et al.
- 通讯作者:et al.
An RNA-binding protein αCP-1 is involved in the STAT3-mediated suppression of NF-κB transcriptional activity
- DOI:10.1093/intimm/dxm026
- 发表时间:2007-05-01
- 期刊:
- 影响因子:4.4
- 作者:Nishinakamura, Hitomi;Minoda, Yasumasa;Kobayashi, Takashi
- 通讯作者:Kobayashi, Takashi
A novel Zinc finger protein, ZCCHC11, interacts with TIFA and modulates TLR signaling
新型锌指蛋白 ZCCHC11 与 TIFA 相互作用并调节 TLR 信号转导
- DOI:10.1016/j.bbrc.2006.04.006
- 发表时间:2006-06-09
- 期刊:
- 影响因子:3.1
- 作者:Minoda, Yasumasa;Saeki, Kazuko;Yoshimura, Akihiko
- 通讯作者:Yoshimura, Akihiko
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAKAESU Giichi其他文献
TAKAESU Giichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAKAESU Giichi', 18)}}的其他基金
Molecular mechanisms of cell death in macrophages and foam cells
巨噬细胞和泡沫细胞细胞死亡的分子机制
- 批准号:
15K08429 - 财政年份:2015
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel regulatory mechanism of cell death in macrophages
巨噬细胞细胞死亡的新调控机制
- 批准号:
25860322 - 财政年份:2013
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Cross-regulatory mechanisms of innate immunity and autophagy
先天免疫和自噬的交叉调节机制
- 批准号:
20790376 - 财政年份:2008
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
相似海外基金
Induction of adaptive immune responses against respiratory viruses using in ovo delivered toll-like receptor (TLR) ligands
使用卵内传递的 Toll 样受体 (TLR) 配体诱导针对呼吸道病毒的适应性免疫反应
- 批准号:
491522-2015 - 财政年份:2018
- 资助金额:
$ 2.57万 - 项目类别:
Collaborative Research and Development Grants
Elucidation of the mechanism of cardiac remodeling and arrhythmogenesis via toll-like receptor (TLR) 9
通过 Toll 样受体 (TLR) 9 阐明心脏重塑和心律失常发生的机制
- 批准号:
18K08077 - 财政年份:2018
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Induction of adaptive immune responses against respiratory viruses using in ovo delivered toll-like receptor (TLR) ligands
使用卵内传递的 Toll 样受体 (TLR) 配体诱导针对呼吸道病毒的适应性免疫反应
- 批准号:
491522-2015 - 财政年份:2017
- 资助金额:
$ 2.57万 - 项目类别:
Collaborative Research and Development Grants
Molecular approaches to identify toll-like receptor (TLR) signaling mechanisms in vaccinia virus specific immunity
鉴定牛痘病毒特异性免疫中 Toll 样受体 (TLR) 信号传导机制的分子方法
- 批准号:
356358-2008 - 财政年份:2009
- 资助金额:
$ 2.57万 - 项目类别:
Discovery Grants Program - Individual
Suppression of Immune Toll-like receptor (TLR) signaling by Hepatitis B e Antigen (HBeAg)
乙型肝炎 e 抗原 (HBeAg) 抑制免疫 Toll 样受体 (TLR) 信号转导
- 批准号:
nhmrc : 491017 - 财政年份:2008
- 资助金额:
$ 2.57万 - 项目类别:
NHMRC Project Grants
Molecular approaches to identify toll-like receptor (TLR) signaling mechanisms in vaccinia virus specific immunity
鉴定牛痘病毒特异性免疫中 Toll 样受体 (TLR) 信号传导机制的分子方法
- 批准号:
356358-2008 - 财政年份:2008
- 资助金额:
$ 2.57万 - 项目类别:
Discovery Grants Program - Individual
上気道炎症の病態形成におけるToll-like receptor(TLR)の役割
Toll 样受体 (TLR) 在上呼吸道炎症发病机制中的作用
- 批准号:
17659531 - 财政年份:2005
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Exploratory Research
Role of toll-like receptor (TLR)4 and CD14 in initiation of innate immunity against viruses
Toll样受体(TLR)4和CD14在启动针对病毒的先天免疫中的作用
- 批准号:
nhmrc : 303284 - 财政年份:2004
- 资助金额:
$ 2.57万 - 项目类别:
Early Career Fellowships
Toll-like receptor (TLR) independent immunogenicity of antigen expressing apoptotic (tumor)cells (B03)
表达凋亡(肿瘤)细胞抗原的 Toll 样受体 (TLR) 独立免疫原性 (B03)
- 批准号:
5158736 - 财政年份:1999
- 资助金额:
$ 2.57万 - 项目类别:
Collaborative Research Centres
Clinical Trail of Vaccine in Combination with Toll-Like Receptor (TLR)
疫苗联合Toll样受体(TLR)的临床试验
- 批准号:
8332332 - 财政年份:
- 资助金额:
$ 2.57万 - 项目类别: